ZBHNYSE

Zimmer Biomet Holdings Inc.

Healthcare·Oncology·Commercial·Warsaw, IN, United States
OncologyNeurologyImmunologyOphthalmologyInfectious DiseasePainDermatologyMusculoskeletal

Zimmer Biomet Holdings Inc. (ZBH): 284 pipeline candidates · ~6 mo cash runway · 90 clinical trials. Updated within the last hour.

5.4/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway1.6

5.6 months

Financial Health7.6

D/E 0.79

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

284 candidates

Catalyst MomentumN/A

N/A

Insider Signal2.2

0 buys · 4 sells (180d)

A transparent, data-derived signal for Zimmer Biomet Holdings Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$16.9B

Cash

$424.2M

Quarterly Burn

$953.3M

Runway

5.6 mo

Revenue

$2.1B

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Dec 2026
Today~7 mo out
Catalyst within runway

Pipeline (284 candidates)

Showing 10 of 284 candidates. Sign up for full pipeline.

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

912

Total value held

$16.31B

HolderSharesValue
vanguard capital management llc25,586,824$2.31B
dodge & cox23,542,700$2.13B
blackrock, inc.15,340,806$1.39B
harris associates l p12,959,939$1.17B
state street corp8,825,127$800.1M
vanguard portfolio management llc8,650,228$782.2M
franklin resources inc5,452,665$493.0M
geode capital management, llc5,379,525$484.6M
american century companies inc3,963,206$358.4M
primecap management co/ca/3,907,150$353.3M

Showing top 10 of 912 institutional holders of Zimmer Biomet Holdings Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

90 clinical trials·366 FDA decisions·CEO: Mr. Ivan Tornos

Frequently asked questions

How many drug candidates are in Zimmer Biomet Holdings Inc.'s pipeline?

Zimmer Biomet Holdings Inc. (ZBH) has 284 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Zimmer Biomet Holdings Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Zimmer Biomet Holdings Inc. has approximately 5.6 months of cash runway.

What is Zimmer Biomet Holdings Inc.'s market capitalization?

Zimmer Biomet Holdings Inc.'s market capitalization is approximately $16.9B.

Who is the CEO of Zimmer Biomet Holdings Inc.?

Mr. Ivan Tornos is the chief executive officer of Zimmer Biomet Holdings Inc. (ZBH).

Get the full picture on Zimmer Biomet Holdings Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.